# HCSC Blood Center – FDA Inspection, May 2, 2024

Source: https://www.keypedia.com/records/fda_inspections/hcsc-blood-center/f0f7f4b7-24e0-47e7-ad57-502444226a66
Source feed: FDA_Inspections

> FDA inspection 1240925 of HCSC Blood Center, May 02, 2024. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240925
- Company Name: HCSC Blood Center
- Inspection Date: 2024-05-02
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1113069 - 2019-12-11
- FDA Inspection 1021883 - 2017-07-06
- FDA Inspection 938428 - 2015-08-06
- [FDA Inspection 843504 - 2013-08-08](https://www.keypedia.com/records/fda_inspections/hcsc-blood-center/01eefb46-bf09-4870-9727-50e4ac854961)
- FDA Inspection 740170 - 2011-08-18

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/kish-bolden/e24957d4-927f-40c7-a7ca-860fedce2e3f)

Company: https://www.keypedia.com/companies/hcsc-blood-center/e27e33d7-4b37-4e17-b29a-abbce6ed5218

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d